Premium
Anti‐proliferative activity of a new class of taxanes (14β‐hydroxy‐10‐deacetylbaccatin III derivatives) on multidrug‐resistance‐positive human cancer cells. Int. J. Cancer, 72, 844–850 (1997)
Author(s) -
Distefano M.,
Scambia G.,
Ferlini C.,
Gaggini C.,
De Vincenzo R.,
Riva A.,
Bombardelli E.,
Ojima I.,
Fattorossi A.,
Benedetti Panici P.,
Mancuso S.
Publication year - 1998
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/(sici)1097-0215(19980330)76:1<164::aid-ijc25>3.0.co;2-b
Subject(s) - multiple drug resistance , regret , int , cancer , cancer cell , biology , cancer research , medicine , drug resistance , mathematics , genetics , computer science , statistics , operating system
Distefano, M., Scambia, G., Ferlini, C., Gaggini, C., De Vincenzo, R., Riva, A., Bombardelli, E., Ojima, I., Fattorossi, A., Benedetti Panici, P. and Mancuso, S., Anti‐proliferative activity of a new class of taxanes (14β‐hydroxy‐10‐deacetylbaccatin III derivatives) on multidrug‐resistance‐positive human cancer cells. Int. J. Cancer, 72, 844–N850 (1997). The incorrect version of Figure 2 was published in the above‐noted article. The correct version of the figure is printed here along with the legend. The Authors regret the error.